Le Lézard
Classified in: Health, Science and technology
Subject: AWD

Fast Company Lists SOPHiA GENETICS in Prestigious' Top 10 Most Innovative Companies in Biotech for 2018


LAUSANNE, Switzerland, Feb. 20, 2018 /CNW/ - SOPHiA GENETICS, global leader in Data-Driven Medicine, has been ranked 5th in Fast Company's Top 10 Most Innovative Companies in Biotech. The ranking recognizes companies that exemplify the best in business and innovation in their respective fields.

(Logo: https://mma.prnewswire.com/media/643891/Fast_Company_2018_Sophia_Genetics_Logo.jpg)

SOPHiA GENETICS' AI platform helps clinicians effectively diagnose and treat their patients. The company's Artificial Intelligence, SOPHiA, solves the complexity of genomic data analysis by accurately detecting disease-causing mutations in 5 disorders areas: hereditary cancer, oncology, cardiology, metabolism and pediatrics. To date, SOPHiA has been deployed across over 400 hospitals in 55 countries and has helped to better diagnose over 177'000 patients worldwide.

Fast Company's Top 10 lists recognize pioneering companies across 36 categories, from artificial intelligence to wellness. More than three dozen Fast Company editors, reporters, and contributors surveyed thousands of companies to create these lists.

ABOUT SOPHiA GENETICS 

SOPHiA GENETICS: global leader in Data-Driven Medicine, SOPHiA GENETICS is a health tech company which has developed SOPHiA AI, the most advanced technology for clinical genomics, helping healthcare professionals better diagnose and treat patients. The global network of 410 institutions from 55 countries that use the SOPHiA DDM® analytical platform powered by SOPHiA form the world's largest clinical genomics community. By enabling the rapid adoption of genomic testing worldwide, turning data into actionable clinical insights, and sharing knowledge through its community, SOPHiA GENETICS is democratizing Data-Driven Medicine to save lives equally. The company's achievements were recognized by MIT Technology Review who ranked it amongst the 50 Smartest Companies in 2017. More info: http://www.sophiagenetics.com

SOPHiA GENETICS is on Twitter, follow @SOPHiAGENETICS

ABOUT FAST COMPANY  

Fast Company is the world's leading progressive business media brand, with a unique editorial focus on innovation in technology, ethical economics, leadership, and design. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, one of the U.S.'s leading media companies.

SOURCE SOPHiA GENETICS


These press releases may also interest you

at 01:00
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ?  Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

23 avr 2024
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

23 avr 2024
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...



News published on and distributed by: